We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nutrien (NTR) Up 6% Since Last Earnings Report: Can It Continue?
Read MoreHide Full Article
It has been about a month since the last earnings report for Nutrien (NTR - Free Report) . Shares have added about 6% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Nutrien due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Nutrien's Earnings Miss Estimates in Q4, Revenues Up Y/Y
Nutrien recorded profits of $580 million or $1.18 per share for the fourth quarter of 2025, surging from $118 million or 23 cents in the year-ago quarter.
Barring one-time items, adjusted earnings per share were 83 cents per share, up from 31 cents a year ago. The bottom line missed the Zacks Consensus Estimate of 87 cents.
Sales rose around 5% year over year to $5,340 million in the quarter. The figure beat the Zacks Consensus Estimate of $5,207.3 million.
Segment Highlights
Sales in the Nutrien Ag Solutions (Retail) segment fell 1% year over year to $3,144 million in the quarter. In the fourth quarter, crop nutrients sales and gross margin fell due to lower sales volumes and a weather-shortened fall window in the United States and lower demand for phosphate. The figure beat our estimate of $2,883.3 million.
The Potash division reported a 37% year-over-year increase in sales, totaling $736 million. The metric missed our estimate of $857.9 million. Fourth-quarter sales rose due to higher selling prices and volumes.
The Nitrogen segment posted sales of $1,093 million, up approximately 11% year over year. The figure beat our estimate of $657.6 million. In the fourth quarter of 2025, sales volumes declined due to the earlier announced controlled shutdown of the Trinidad facility and planned turnarounds at North American operations.
The Phosphate segment generated sales of $483 million, up around 17% year over year. The figure exceeded our estimate of $288.1 million.
Financials
At the end of the quarter, Nutrien had cash and cash equivalents of $701 million, down around 18% year over year. Long-term debt was $9,350 million, which increased 5.3% year over year.
Cash provided in operating activities was $2,977 million in the reported quarter.
Outlook
The company projects retail adjusted EBITDA of $1.75 to $1.95 billion for 2026, with the midpoint reflecting high-single digit growth in proprietary products gross margins, a mid-single digit increase in North American crop nutrient sales volumes, improved weather conditions in Australia and cost reduction initiatives across all geographies.
Potash sales volumes are expected to be 14.1–14.8 million tons, in line with the company’s global shipment estimates. Nitrogen sales volumes are forecast at 9.2–9.7 million tons, factoring in no additional production from the Trinidad and New Madrid facility.
Phosphate sales volumes are expected to be 2.4–2.6 million tons, supported by operational improvement actions.
Capital expenditures are projected at $2–$2.1 billion, consistent with 2025, including $400 million in growth investments targeting proprietary products, network optimization, digital capabilities, nitrogen brownfield expansions and potash mine automation. The effective tax rate on adjusted net earnings has been projected at 24–26%.
Finance Costs, and Depreciation and Amortization are expected to be $0.65-$0.75 billion and $2.4-$2.5 billion, respectively.
How Have Estimates Been Moving Since Then?
Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.
VGM Scores
At this time, Nutrien has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock has a score of A on the value side, putting it in the top quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Nutrien has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Nutrien (NTR) Up 6% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Nutrien (NTR - Free Report) . Shares have added about 6% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Nutrien due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Nutrien's Earnings Miss Estimates in Q4, Revenues Up Y/Y
Nutrien recorded profits of $580 million or $1.18 per share for the fourth quarter of 2025, surging from $118 million or 23 cents in the year-ago quarter.
Barring one-time items, adjusted earnings per share were 83 cents per share, up from 31 cents a year ago. The bottom line missed the Zacks Consensus Estimate of 87 cents.
Sales rose around 5% year over year to $5,340 million in the quarter. The figure beat the Zacks Consensus Estimate of $5,207.3 million.
Segment Highlights
Sales in the Nutrien Ag Solutions (Retail) segment fell 1% year over year to $3,144 million in the quarter. In the fourth quarter, crop nutrients sales and gross margin fell due to lower sales volumes and a weather-shortened fall window in the United States and lower demand for phosphate. The figure beat our estimate of $2,883.3 million.
The Potash division reported a 37% year-over-year increase in sales, totaling $736 million. The metric missed our estimate of $857.9 million. Fourth-quarter sales rose due to higher selling prices and volumes.
The Nitrogen segment posted sales of $1,093 million, up approximately 11% year over year. The figure beat our estimate of $657.6 million. In the fourth quarter of 2025, sales volumes declined due to the earlier announced controlled shutdown of the Trinidad facility and planned turnarounds at North American operations.
The Phosphate segment generated sales of $483 million, up around 17% year over year. The figure exceeded our estimate of $288.1 million.
Financials
At the end of the quarter, Nutrien had cash and cash equivalents of $701 million, down around 18% year over year. Long-term debt was $9,350 million, which increased 5.3% year over year.
Cash provided in operating activities was $2,977 million in the reported quarter.
Outlook
The company projects retail adjusted EBITDA of $1.75 to $1.95 billion for 2026, with the midpoint reflecting high-single digit growth in proprietary products gross margins, a mid-single digit increase in North American crop nutrient sales volumes, improved weather conditions in Australia and cost reduction initiatives across all geographies.
Potash sales volumes are expected to be 14.1–14.8 million tons, in line with the company’s global shipment estimates. Nitrogen sales volumes are forecast at 9.2–9.7 million tons, factoring in no additional production from the Trinidad and New Madrid facility.
Phosphate sales volumes are expected to be 2.4–2.6 million tons, supported by operational improvement actions.
Capital expenditures are projected at $2–$2.1 billion, consistent with 2025, including $400 million in growth investments targeting proprietary products, network optimization, digital capabilities, nitrogen brownfield expansions and potash mine automation. The effective tax rate on adjusted net earnings has been projected at 24–26%.
Finance Costs, and Depreciation and Amortization are expected to be $0.65-$0.75 billion and $2.4-$2.5 billion, respectively.
How Have Estimates Been Moving Since Then?
Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.
VGM Scores
At this time, Nutrien has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock has a score of A on the value side, putting it in the top quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Nutrien has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.